Cadila Healthcare Ltd.

NSE: CADILAHC | BSE: 532321 | ISIN: INE010B01027 |Industry: Pharmaceuticals
|Falling Comet

Cadila Healthcare Ltd.    
29 Oct 2021


  • Zydus Cadila posts consolidated revenues of Rs. 3785 crores in Q2, up 3% on a y-o-y basis.
  • Earnings before Interest, Depreciation and Tax (EBIDTA) for the quarter was Rs. 861 crores, up by 6% y-o-y.
  • The EBIDTA margin for the quarter was 22.7%, an improvement of 50 basis points on a y-o-y basis.
  • Profit After Tax (PAT) stood at Rs. 597 crores, up 6% on a y-o-y basis.



Result PDF

Cadila Healthcare Ltd. has an average target of 645.33 from 6 brokers.
More from Cadila Healthcare Ltd.